@FiercePharma: Fake Avastin probe hits a dead end at an apparent dummy address in Cairo--Reuters. News | Follow @FiercePharma
> Strong sales of the anticoagulant Angiomax boosted Medicines Co. profits past analyst esimates as revenues hit $124.2 million. Report
> Johnson & Johnson ($JNJ) offered concessions to European antitrust regulators to ease concerns over its proposed buyout of Swiss device maker Synthes. News
> Ben Venue Laboratories has spawned another recall, as its Bedford Labs unit yanks three lots of the leukemia treatment cytarabine. Item
> Canada's Paladin Labs plans to buy almost 45% of South Africa's Litha Healthcare in a complicated deal that also ropes in its previously planned buyout of marketing-and-sales provider Pharmaplan. Report
> Veterinary products firm Dechra said its drug sales showed strong growth, as pet owners continued to treat their animals despite the troubled economy. Article
> Beginning March 1, European regulators will publish information on drug-approval applications on a regular basis as part of an ongoing push toward transparency. News
> Omnicare dropped its takeover bid for rival PharMerica after U.S. antitrust regulators sued to block the deal. Story
> U.S. business leaders and trade groups asked the Justice Department to clarify the Foreign Corrupt Practices Act as the government continues to press forward with several high-profile foreign bribery investigations. Report
Biotech News
@FierceBiotech: Venture backer makes $7M bet on cardio drug tech that could rival stents. News | Follow @FierceBiotech
@RyanMFierce: Good stuff from @LifeSciVC on how much milestone money #biotech investors are actually getting in biobuck-laden M&As. News | Follow @RyanMFierce
@MarkHFierce: EyeGates' new ocular drug delivery system showed promise in Phase III. Results presented in Dubai!! More | Follow @MarkHFierce
@FierceMedDev: DNA in Play as Life Technologies Joins Illumina in Race for Deal: Real M&A via @BloombergNews. Item | Follow @FierceMedDev
> Venture backer makes $7M bet on cardio drug tech that could rival stents. Article
> Collegium Pharma scores $22M round for abuse-preventing painkiller in Phase III. More
> Biotech VCs wait for big checks from string of buyout deals. Story
> Eisai co-developing cancer drug fueled by bacteria; U.S. trials launch soon. Item
Drug Delivery News
> Anaeropharma/Eisai launch bacteria-based cancer combo drug trial. Story
> Sol-Gel seals $27M dermatology drug delivery deal with mystery partner. News
> EyeGate discloses positive Phase III data for electric eye drug device. Article
> Harvard's tiny DNA robots deliver cancer-killing treatment in lab. Item
> Carbon nanoparticles charge up old cancer treatment to powerful effect. More
> MicroCHIPS' wireless implantable device delivered osteoporosis drug in people. Story
Biomarker News
> Genomind begins depression biomarker study. Item
> Imaging biomarker shows autism in infancy. Story
> Biomarkers watching HIV progression. Article
> Cyclin D1 could predict outcomes in oral cancer. News
Medical Device News
> J&J's Weldon to step down as CEO, leaving post to Gorsky. More
> New Enzo test aims to boost colonoscopy compliance. Story
> Vascular Magnetics snags $7M in Series A. News
> Medtronic might consider spine unit sale. Article
And Finally... Aspirin could help block cervical cancer in women with HIV and should be studied for that purpose, researchers said. Report